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unrelated defects may be the result of a common mechanism: altered
neural crest cell migration. Further embryonic and genetic experimen-
tation will likely clarify the role of the neural crest cell at the various
levels of cardiac development.
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Novel management strategy for severe cyanosis after Sano modification
of the Norwood procedure
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Sano modification of the Norwood procedure has resultedin a more favorable distribution of systemic, pulmonary,and coronary blood flow. However, frequently thesepatients present with severe cyanosis caused by dynamic
proximal shunt stenosis. The purpose of this review was to eval-
uate a management strategy for severe cyanosis in this patient
population.
Methods
Between September 2003 and September 2004, 22 newborns un-
derwent Sano modification at Children’s Healthcare of Atlanta.
One patient died before hospital discharge and was excluded from
further analysis. Four (19%) of the 21 remaining patients presented
at 53  26 days of age with oxygen saturations of less than 70%.
These 4 patients (group 1) were compared with the remaining 17
(group 2). Management strategy to treat cyanosis in group 1
patients consisted of increasing preload and -blockade. Age-
matched hemodynamic data were evaluated between group 1 be-
fore therapy and group 2; variables before and after therapy in
group 1 were also evaluated.
Results
Sano shunt size was 6 mm (n  3; birth weight, 3 kg) and 5 mm
(n  1; birth weight, 2 kg; group 1) versus a shunt size of 6 mm
(n  13; 4 patients with a birth weight 3 kg; 9 patients with a
birth weight 3 kg) and 5 mm (n  4; birth weight, 3 kg; group
2). Hemodynamic variables before and after therapy in group 1 are
shown in Table 1. In addition, comparison was made between
hemodynamic variables at the time of presentation with cyanosis
group 1 and group 2 at the same age (Table 2).
This management strategy prolonged the timing to bidirectional
Glenn shunt by 70  40 days in group 1. A bidirectional Glenn
shunt was performed at 123  32 days in group 1 (4/4 patients)
versus 133  28 days in group 2 (11/13 patients, P  .6).
Discussion
Secondary to the variable pulmonary and systemic vascular resis-
tance ratio, the net effect of the Norwood procedure with a sys-
temic–pulmonary artery shunt is runoff from the systemic to the
pulmonary bed during diastole, resulting in a low diastolic blood
pressure, a wider pulse pressure, and a change in the pattern of
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No. of patients 4 4 1.0
Oxygen saturation (%) 62 9 80  3 .01
Heart rate (beats/min) 151 13 129 9 .03
Respiratory rate (breaths/min) 60 10 50 22 .4
Systolic blood pressure (mm Hg) 90 1 90  12 1.0
Diastolic blood pressure (mm Hg) 44 8 49  13 .5
Mean blood pressure (mm Hg) 60 5 63  11 .5
RVOT proximal gradient (mm Hg) 92 12 58 13 .02
Mean  SD; paired 2-tailed t test. RVOT, Right ventricular outflow tract.
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coronary perfusion.1 Sano modification, substituting a right ven-
tricle–pulmonary artery shunt in place of the systemic–pulmonary
artery shunt, provides a more favorable distribution of systemic,
pulmonary, and coronary blood flow. Several studies have reported
a hemodynamic profile with higher diastolic pressure,2,3 narrowed
pulse pressure,2,3 and higher coronary perfusion pressure2 after a
right ventricle–pulmonary artery shunt compared with that after a
systemic–pulmonary artery shunt.
In our recent experience, 4 (19%) of 21 patients after Sano
modification presented at 53  26 days of age with systemic
oxygen saturation of less than 70% caused by dynamic proximal
shunt stenosis. The proximal shunt Doppler gradient determined
by transthoracic echocardiography was 92  12 mm Hg. The
gradient was due to dynamic obstruction below the ventricular
anastomosis site of the right ventricle–pulmonary artery shunt. We
believe that this mechanism of significant cyanosis after the Sano
modification is similar to that of hypercyanotic episodes in tetral-
ogy of Fallot: dynamic outflow obstruction. Therefore, we adopted
a management strategy of increased preload and -blockade sim-
ilar to the treatment strategy for the hypercyanotic episode in
patients with tetralogy of Fallot.
Increasing preload was achieved by volume bolus (3 pa-
tients) and decreasing diuretic therapy (4 patients). -Blockade
therapy was with propranolol (1 mg · kg1 · d1) in 3 patients
and esmolol in 1 patient. This patient was converted to sotalol
instead of propranolol because of atrial dysrhythmias not re-
sponsive to propranolol. This combination therapy resulted in a
22% increase in systemic oxygen saturation (from 62%  9% to
80%  3%), with a 15% decrease in heart rate (from 151  13
to 129  9 beats/min).
Increased preload in these single-ventricle patients results in
increased systemic resistance, allowing more blood flow into the
pulmonary circuit. Increased cardiac output and pulmonary blood
flow leads to increased systemic oxygen saturations. -Blocker
therapy has been shown to increase systemic saturation in patients
with tetralogy of Fallot through a variety of complex mechanisms,
including increases in peripheral resistance,4 prevention of tachy-
cardia, and shift in the hemoglobin-oxygen dissociation curve.5
Increased peripheral resistance again allows for increased pulmo-
nary blood flow in this single-ventricle patient. A slower heart rate
allows for increased ventricular filling time and thus increased
preload. Shifting the hemoglobin-oxygen dissociation curve re-
sults in increased availability of oxygen delivery to the tissues. The
overall result is improvement in systemic oxygen saturations.
Conclusion
The medical management strategy of increasing preload and ini-
tiating -blockade therapy is effective in the treatment of severe
cyanosis caused by dynamic proximal shunt stenosis after Sano
modification of the Norwood procedure.
References
1. Vogel MA, Rychik J, Vetter J, Donofrio MT, Jacobs M. Effect of
volume unloading surgery on coronary flow dynamics in patients with
aortic atresia. J Thorac Cardiovasc Surg. 1997;113:718-27.
2. Maher KO, Pizarro C, Gidding SS, Januszewska K, Malec E, Norwood
WI Jr, et al. Hemodynamic profile after the Norwood procedure with
right ventricle to pulmonary artery conduit. Circulation. 2003;108:
782-4.
3. Bradley SM, Simsic JM, McQuinn TC, Habib DM, Shirali GS, Atz AM.
Hemodynamic status following the Norwood procedure: a comparison
of right ventricle to pulmonary artery versus modified Blalock-Taussig
shunt. Ann Thorac Surg. 2004;78:933-41.
4. Honey M, Chamberlain DA, Howard J. The effect of beta-sympathetic
blockade on arterial oxygen saturation in Fallot’s tetralogy. Circulation.
1964;30:501-6.
5. Oski FA, Miller LD, Dellvoria-Papadopoulos M, Manchester JH, Shel-
burn JC. Oxygen affinity in red cells: changes induced in vivo by
propranolol. Science. 1972;175:1372-3.
TABLE 2. Hemodynamic variables at the time of presenta-
tion with cyanosis in group 1 and patients in group 2 at the
same age
Group 1 Group 2 P value
No. of patients 4 17
Age at the time of the operation (d) 5 3 5  3 1.0
Birth weight (kg) 3.1 0.8 3.2 0.5 1.0
Cardiopulmonary bypass time (min) 135 16 147 28 .3
Total ischemic time (min) 60 3 65 14 .1
Age with cyanosis (d) 53 26 56 13 .8
Oxygen saturation (%) 62 9 80 3 .02
Heart rate (beats/min) 151 13 142 11 .3
Respiratory rate (beats/min) 60 10 52 11 .3
Systolic blood pressure (mm Hg) 90 1 85 8 .5
Diastolic blood pressure (mm Hg) 44 8 48 8 .5
Mean blood pressure (mm Hg) 60 5 60 7 .9
RVOT proximal gradient (mm Hg) 92 12 44 17 .0003
Mean  SD; paired 2-tailed t test. RVOT, Right ventricular outflow tract.
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